Literature DB >> 2508580

[The pre-climacteric patient].

H P Zahradnik1.   

Abstract

In spite of menstrual bleedings during premenopause FSH-concentration in blood increases significantly, however, without reaching post-menopausal amounts. Sometimes it is correlated with climacteric symptoms. FSH increases already 10 years before menopause, whereas LH does not change. Responsible for that is the partial reduction of follicular function, especially the loss of inhibin. Just during this time contraception is very important. Sometimes a therapy with sex steroids is necessary.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508580     DOI: 10.1007/bf02417644

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

1.  Age and activity effects on rate of bone mineral loss.

Authors:  D M Smith; M R Khairi; J Norton; C C Johnston
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

2.  Endometrial hyperplasia in relation to genital function.

Authors:  R SCHRODER
Journal:  Am J Obstet Gynecol       Date:  1954-07       Impact factor: 8.661

3.  The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.

Authors:  B M Sherman; J H West; S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

4.  Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.

Authors:  S Chakravarti; W P Collins; M H Thom; J W Studd
Journal:  Br Med J       Date:  1979-04-14

5.  [The symptomatology of the climacteric (author's transl)].

Authors:  G A Hauser
Journal:  Ther Umsch       Date:  1974-03

6.  Age-related loss of trabecular bone in premenopausal women: a biopsy study.

Authors:  R Marcus; J Kosek; A Pfefferbaum; S Horning
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

7.  Vasomotor flushes and the release of peripheral immunoreactive luteinizing hormone-releasing hormone in postmenopausal women.

Authors:  V Ravnikar; K Elkind-Hirsch; I Schiff; K J Ryan; D Tulchinsky
Journal:  Fertil Steril       Date:  1984-06       Impact factor: 7.329

Review 8.  Ovarian failure and ageing.

Authors:  J W Studd; M H Thom
Journal:  Clin Endocrinol Metab       Date:  1981-03

Review 9.  Oestrogen replacement therapy: physiological considerations and new applications.

Authors:  H L Judd
Journal:  Baillieres Clin Endocrinol Metab       Date:  1987-02

10.  Menopausal flushes: effect of pituitary gonadotropin desensitization by a potent luteinizing hormone- releasing factor agonist.

Authors:  R F Casper; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.